The agency used a ‘new approach’ to broaden the drug’s indication to include patients with BCG-unresponsive non-muscle invasive bladder cancer whose tumors are papillary-only.
Medscape Medical News
Source link
The agency used a ‘new approach’ to broaden the drug’s indication to include patients with BCG-unresponsive non-muscle invasive bladder cancer whose tumors are papillary-only.
Medscape Medical News
Source link